Interestingly, a previously published study demonstrated that cotargeting of BRD4 and MAPK signaling promoted cell death in a NF1 loss-of-function mouse model of malignant peripheral nerve sheath tumor (MPNST) (55). This evidence concerns the gene BRD4 and malignant peripheral nerve sheath tumor.